Jean-Christophe Dantonel

Jean-Christophe Dantonel is a seasoned professional with extensive experience in the health and biotechnology sectors. Currently serving as Managing Partner at iBionext and Board Member at both Vect-Horus and Tilak Healthcare, Jean-Christophe previously held board positions at EUROAPI and directed health and biotechnology initiatives at the Secrétariat général pour l'investissement for over a decade. With a strong academic background, including a Ph.D. in Genetics from the University of Strasbourg and an MBA from Sciences Po, Jean-Christophe has demonstrated expertise in international project management and oncology. Significant achievements include leading clinical trials, publishing in top scientific journals, and contributing to biotech project strategies and negotiations throughout a diverse career.